PAVmed subsidiary Veris Health awarded $1.8M NIH grant for cancer care

PAVmed and its majority-owned digital health subsidiary Veris Health announced that Veris has been awarded a $1.8M grant from the National Institute on Minority Health and Health Disparities – NIMHD -, an institute of the National Institutes of Health – NIH -. The two-year grant will fund research to optimize and validate the Veris Cancer Care Platform for the needs of medically underserved cancer patients, in partnership with an academic cancer center. The research project will focus on patients facing language barriers, limited access to technology, and socioeconomic disparities.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue